- Home
- AMWD vs OPK Comparison
AMWD vs OPK Comparison
Compare AMWD & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMWD | OPK |
|---|---|---|
| Founded | 1980 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 566.8M | 921.2M |
| IPO Year | 1995 | 2011 |
Fundamental Metrics
Financial Performance| Metric | AMWD | OPK |
|---|---|---|
| Price | $47.55 | $1.47 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $59.50 | $1.60 |
| AVG Volume (30 Days) | 355.2K | ★ 2.3M |
| Earning Date | 05-28-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,709,585,000.00 | $606,879,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $33.29 | $0.98 |
| 52 Week High | $72.16 | $1.60 |
Technical Indicators
Market Signals| Indicator | AMWD | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 69.39 | 82.58 |
| Support Level | $47.15 | $1.25 |
| Resistance Level | $58.38 | $1.52 |
| Average True Range (ATR) | 2.26 | 0.06 |
| MACD | 1.08 | 0.03 |
| Stochastic Oscillator | 98.44 | 89.41 |
Price Performance
Historical ComparisonAbout AMWD American Woodmark Corporation
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.